Apixaban (ATC-Code: B01AF02)

TENDER DESCRIPTION

This notice is intended for the conclusion of agreements relating to the active ingredient “Apixaban (ATC code: B01AF02)” with pharmaceutical companies within the meaning of Section 130a(8) sentence 1 of Book Five of the German Social Code (SGB V) (rebate agreements). Pursuant to Section 130a(8) sentence 1 of SGB V, the invitation to participate is addressed only to pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs within the meaning of Section 4(18) of the German Medicines Act (AMG). This is not an Open Procedure; rather, it is a publication of the invitation to conclude/accede to rebate agreements with conditions that are set for all participants and are non-negotiable, including the amount of the rebate. The relevant information under point 2.1 “type of procedure” as well as under point 5.1.12 “condition for the award of the contract here: deadline until which the tender must remain valid” is attributable only to the structure of this form template. Contracting parties may become any number of pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs within the meaning of Section 4(18) of the Medicines Act (AMG). The contract is…

TENDER BRIEF

TENDER DOCUMENTS